封面
市場調查報告書
商品編碼
1627984

骨科器材市場機會、成長動力、產業趨勢分析及 2024 年至 2032 年預測

Orthopedic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年,全球骨科器材市場規模達到523億美元,預計2024年至2032年複合年成長率為3.8%。

技術創新在推動市場成長方面發揮關鍵作用。 3D 列印植入物、個人化矯形設備和機器人輔助手術工具等發展正在提高精確度並改善患者的治療效果。這些進步使外科醫生能夠更準確地執行複雜的手術,從而縮短康復時間並提高患者滿意度。微創手術技術的日益普及做出了重大貢獻,因為這些手術可以降低風險、縮短住院時間並加快康復速度,使其越來越受到患者和醫療保健提供者的歡迎。

市場依產品細分為創傷固定裝置、關節鏡裝置、重建裝置、脊椎裝置、矯形生物製劑等。關節重建設備預計將強勁成長,預計到 2032 年複合年成長率為 4.5%,達到 291 億美元。此細分市場的擴張主要是由於骨科疾病發生率上升,尤其是老年人的發生率上升。骨關節炎和退化性關節疾病等疾病越來越常見,導致關節重建手術的需求激增。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 523 億美元
預測值 734 億美元
複合年成長率 3.8%

按最終用途分類,市場分為醫院和診所、門診手術中心和其他設施。醫院和診所在市場中佔據主導地位,預計到 2032 年其收入將達到 402 億美元。 這些機構因其先進的手術能力、全面的成像和診斷工具以及綜合復健服務而成為骨科護理的主要提供者。醫院擁有專業設備和專業知識,可確保為複雜的骨科病例提供高品質的護理。

從地理上看,北美地區 2023 年市場收入為 293 億美元,預計 2024 年至 2032 年複合年成長率為 3%。隨著人口老化的增加,關節炎和骨質疏鬆症等疾病變得更加普遍,從而增加了對骨科干預措施的需求。此外,北美先進的醫療基礎設施和對創新手術技術的關注支持了尖端骨科設備的採用,進一步推動了市場擴張。

總之,在技術進步、老年人口不斷成長以及對有效骨科護理解決方案不斷成長的需求的推動下,骨科器械市場將穩步成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 老年人口基數不斷增加
      • 骨科疾病發生率增加
      • 技術進步
      • 已開發國家骨科手術率不斷上升
    • 產業陷阱與挑戰
      • 骨科器械成本過高
      • 嚴格的 FDA 法規和生物相容性問題
  • 成長潛力分析
  • 技術景觀
  • 供應鏈分析
  • 未來市場趨勢
  • 監管環境
  • 報銷場景
  • 投資概況
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 關節重建裝置
    • 髖關節置換術
    • 膝關節置換術
    • 腳踝置換術
    • 肩關節置換術
    • 其他關節重建裝置
  • 脊椎裝置
  • 創傷固定裝置
  • 骨科生物製劑
  • 關節鏡設備
  • 其他產品

第 6 章:市場估計與預測:依最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第 7 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 8 章:公司簡介

  • aap Implantate
  • Alphatec Spine
  • Arthrex
  • B. Braun
  • ConforMIS
  • CONMED
  • DePuy Synthes (Johnson and Johnson)
  • DJO Global
  • Globus Medical
  • Integra LifeSciences
  • Medacta
  • Medtronic
  • Microport Scientific
  • NuVasive
  • Smith & Nephew
  • Stryker
  • TriMed
  • Waldemar LINK
  • Zimmer Biomet
簡介目錄
Product Code: 1501

The Global Orthopedic Devices Market reached USD 52.3 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2032. The market's expansion is fueled by an aging population, increasing prevalence of musculoskeletal disorders, and rapid advancements in medical technology.

Technological innovations are playing a pivotal role in driving market growth. Developments such as 3D-printed implants, personalized orthopedic devices, and robotic-assisted surgical tools are enhancing precision and improving patient outcomes. These advancements are enabling surgeons to perform complex procedures with greater accuracy, leading to faster recovery times and improved patient satisfaction. The growing adoption of minimally invasive surgical techniques contributes significantly, as these procedures offer reduced risks, shorter hospital stays, and quicker recoveries, making them increasingly popular among patients and healthcare providers.

The market is segmented by product into trauma fixation devices, joint arthroscopic devices, reconstruction devices, spinal devices, ortho biologics, and others. Joint reconstruction devices are poised for strong growth, with a CAGR of 4.5% expected through 2032, reaching USD 29.1 billion. This segment's expansion is primarily driven by the rising incidence of orthopedic conditions, particularly among the elderly. Conditions such as osteoarthritis and degenerative joint diseases are increasingly common, leading to a surge in demand for joint reconstruction procedures.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$52.3 Billion
Forecast Value$73.4 Billion
CAGR3.8%

By end use, the market is categorized into hospitals & clinics, ambulatory surgical centers, and other facilities. Hospitals and clinics dominate the market, with their revenue expected to reach USD 40.2 billion by 2032. These institutions are key providers of orthopedic care due to their advanced surgical capabilities, comprehensive imaging and diagnostic tools, and integrated rehabilitation services. The availability of specialized equipment and expertise in hospitals ensures high-quality care for complex orthopedic cases.

Geographically, North America accounted for USD 29.3 billion in market revenue in 2023 and is projected to grow at a CAGR of 3% from 2024 to 2032. The region's growth is driven by a substantial elderly population and a high prevalence of musculoskeletal disorders. As the aging population increases, conditions like arthritis and osteoporosis become more widespread, boosting demand for orthopedic interventions. Additionally, North America's advanced healthcare infrastructure and focus on innovative surgical techniques support the adoption of cutting-edge orthopedic devices, further propelling market expansion.

In conclusion, the orthopedic devices market is set for steady growth, driven by technological advancements, a growing elderly population, and increasing demand for effective orthopedic care solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing base of geriatric population
      • 3.2.1.2 Augmented incidence of orthopedic diseases
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Escalating rate of orthopedic surgeries in developed nations
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Excessive cost of orthopedic devices
      • 3.2.2.2 Stringent FDA regulations and biocompatibility issues
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Supply chain analysis
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Reimbursement scenario
  • 3.9 Investment overview
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Joint reconstruction devices
    • 5.2.1 Hip replacement
    • 5.2.2 Knee replacement
    • 5.2.3 Ankle replacement
    • 5.2.4 Shoulder replacement
    • 5.2.5 Other joint reconstruction devices
  • 5.3 Spinal devices
  • 5.4 Trauma fixation devices
  • 5.5 Orthobiologics
  • 5.6 Arthroscopic devices
  • 5.7 Other products

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals & clinics
  • 6.3 Ambulatory surgical centers
  • 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 aap Implantate
  • 8.2 Alphatec Spine
  • 8.3 Arthrex
  • 8.4 B. Braun
  • 8.5 ConforMIS
  • 8.6 CONMED
  • 8.7 DePuy Synthes (Johnson and Johnson)
  • 8.8 DJO Global
  • 8.9 Globus Medical
  • 8.10 Integra LifeSciences
  • 8.11 Medacta
  • 8.12 Medtronic
  • 8.13 Microport Scientific
  • 8.14 NuVasive
  • 8.15 Smith & Nephew
  • 8.16 Stryker
  • 8.17 TriMed
  • 8.18 Waldemar LINK
  • 8.19 Zimmer Biomet